Pacific Biosciences of California (PACB) Competitors $1.23 0.00 (0.00%) Closing price 09/17/2025 04:00 PM EasternExtended Trading$1.24 +0.01 (+0.41%) As of 09/17/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PACB vs. TXG, HBIO, TMO, A, MTD, WAT, ILMN, TECH, BIO, and CRLShould you be buying Pacific Biosciences of California stock or one of its competitors? The main competitors of Pacific Biosciences of California include 10x Genomics (TXG), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), and Charles River Laboratories International (CRL). Pacific Biosciences of California vs. Its Competitors 10x Genomics Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International Waters Illumina Bio-Techne Bio-Rad Laboratories Charles River Laboratories International 10x Genomics (NASDAQ:TXG) and Pacific Biosciences of California (NASDAQ:PACB) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings. Which has stronger earnings & valuation, TXG or PACB? 10x Genomics has higher revenue and earnings than Pacific Biosciences of California. 10x Genomics is trading at a lower price-to-earnings ratio than Pacific Biosciences of California, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio10x Genomics$610.78M2.62-$182.63M-$0.70-18.37Pacific Biosciences of California$154.01M2.40-$309.85M-$2.29-0.54 Is TXG or PACB more profitable? 10x Genomics has a net margin of -13.13% compared to Pacific Biosciences of California's net margin of -336.40%. 10x Genomics' return on equity of -12.88% beat Pacific Biosciences of California's return on equity.Company Net Margins Return on Equity Return on Assets 10x Genomics-13.13% -12.88% -10.03% Pacific Biosciences of California -336.40%-66.75%-16.90% Do insiders and institutionals believe in TXG or PACB? 84.7% of 10x Genomics shares are owned by institutional investors. 9.4% of 10x Genomics shares are owned by insiders. Comparatively, 2.5% of Pacific Biosciences of California shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more volatility and risk, TXG or PACB? 10x Genomics has a beta of 2, suggesting that its share price is 100% more volatile than the S&P 500. Comparatively, Pacific Biosciences of California has a beta of 1.87, suggesting that its share price is 87% more volatile than the S&P 500. Do analysts recommend TXG or PACB? 10x Genomics currently has a consensus target price of $13.65, indicating a potential upside of 6.17%. Pacific Biosciences of California has a consensus target price of $1.90, indicating a potential upside of 54.47%. Given Pacific Biosciences of California's stronger consensus rating and higher probable upside, analysts clearly believe Pacific Biosciences of California is more favorable than 10x Genomics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 10x Genomics 1 Sell rating(s) 8 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.33Pacific Biosciences of California 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43 Does the media refer more to TXG or PACB? In the previous week, 10x Genomics had 20 more articles in the media than Pacific Biosciences of California. MarketBeat recorded 20 mentions for 10x Genomics and 0 mentions for Pacific Biosciences of California. 10x Genomics' average media sentiment score of 0.86 beat Pacific Biosciences of California's score of 0.64 indicating that 10x Genomics is being referred to more favorably in the media. Company Overall Sentiment 10x Genomics Positive Pacific Biosciences of California Positive Summary10x Genomics beats Pacific Biosciences of California on 13 of the 16 factors compared between the two stocks. Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PACB vs. The Competition Export to ExcelMetricPacific Biosciences of CaliforniaMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$369.46M$6.78B$5.74B$10.30BDividend YieldN/A1.20%5.89%4.62%P/E Ratio-0.5426.5876.6626.52Price / Sales2.40191.65445.5788.86Price / CashN/A21.7137.2260.63Price / Book0.664.9413.946.31Net Income-$309.85M$178.07M$3.29B$271.37M7 Day Performance-2.38%2.87%-0.67%0.59%1 Month Performance-7.52%5.73%3.89%6.22%1 Year Performance-36.27%17.45%86.24%28.35% Pacific Biosciences of California Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PACBPacific Biosciences of California2.3465 of 5 stars$1.23flat$1.90+54.5%-34.2%$369.46M$154.01M-0.54730Positive NewsTXG10x Genomics3.518 of 5 stars$13.35+5.6%$13.65+2.3%-39.9%$1.66B$610.78M-19.071,240HBIOHarvard Bioscience3.952 of 5 stars$0.44-0.5%$2.00+355.1%-84.1%$19.57M$88.75M-0.34490Short Interest ↑Gap DownTMOThermo Fisher Scientific4.9768 of 5 stars$474.73-1.0%$592.24+24.8%-22.6%$179.26B$43.21B27.46125,000Positive NewsEx-DividendAAgilent Technologies4.4654 of 5 stars$125.68+2.0%$140.08+11.5%-8.3%$35.63B$6.51B29.5017,900Dividend AnnouncementAnalyst ForecastAnalyst RevisionMTDMettler-Toledo International4.1052 of 5 stars$1,262.22+0.2%$1,311.11+3.9%-7.8%$26.00B$3.87B31.9617,300Positive NewsWATWaters4.7518 of 5 stars$299.46+1.4%$378.73+26.5%-7.6%$17.83B$3.05B27.007,600Trending NewsILMNIllumina4.7379 of 5 stars$100.92+6.1%$123.06+21.9%-22.5%$15.51B$4.37B12.779,030Positive NewsTECHBio-Techne4.9831 of 5 stars$51.62+0.7%$70.42+36.4%-31.6%$8.09B$1.22B112.223,100Positive NewsBIOBio-Rad Laboratories4.7235 of 5 stars$280.57+0.1%$333.50+18.9%-15.9%$7.59B$2.57B23.927,700Positive NewsCRLCharles River Laboratories International4.6099 of 5 stars$152.47-0.3%$177.07+16.1%-26.1%$7.50B$4.05B-114.6420,100Positive News Related Companies and Tools Related Companies TXG Competitors HBIO Competitors TMO Competitors A Competitors MTD Competitors WAT Competitors ILMN Competitors TECH Competitors BIO Competitors CRL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PACB) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTen Bucks, Five Minutes... Could Send You Up to $8K QUARTERLYDOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredWhy Peter Thiel Hid Gold in a VaultSilicon Valley billionaires hiding gold in vaults? Peter Thiel’s Palantir quietly diverted tens of millions...Golden Portfolio | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredGPT-5 could crash America’s power gridOpenAI’s new GPT-5 model is sparking unprecedented energy demand — research shows it consumes over eight times...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacific Biosciences of California With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PACB Stock Alerts